U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 571 - 580 of 11247 results

Status:
Investigational
Source:
INN:flucindole [INN]
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

FLUCINDOLE, a cyclindole derivative, is an antipsychotic agent with tricyclic structure.
Status:
Investigational
Source:
JAN:CHLORPYRIFOS-METHYL [JAN]
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Chlorpyrifos-methyl is a broad-spectrum organophosphorous insecticide and potential toxic pollutant widely used in agriculture and effective against a wide range of insect pests in commercial importance crops. Chlorpyrifos-methyl have endocrine disruption activity, especially anti-androgenic effects and Chlorpyrifos-methyl administration leads to hepatotoxicity and neurotoxicity in mammals. The fish exposed to chlorpyrifos-methyl exhibited behavioral changes in the form of neurotoxin toxicity: less general activity than control group, loss of equilibrium, erratic swimming and staying motionless at a certain location
Status:
Investigational
Source:
INN:naranol [INN]
Source URL:

Class (Stereo):
CHEMICAL (MIXED)

Naranol is an antidepressant, anxiolytic, and antipsychotic drug.
Status:
Investigational
Source:
NCT04317417: Not Applicable Interventional Active, not recruiting Cancer
(2022)
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Bifenthrin is a pyrethroid insecticide used in urban and agricultural applications. Bifenthrin is a broad-spectrum insecticide that modifies voltage-gated ion channels disrupting the normal function of nerve cells. In May 2010 EU Commission withdrawn plant protection products containing bifenthrin.
Status:
Investigational
Source:
INN:tazifylline
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)


Status:
Investigational
Source:
NCT01785186: Phase 2 Interventional Completed Tuberculosis, Pulmonary
(2013)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

SQ-109 is a [1,2]-diamine-based ethambutol (EMB) analog developed for the treatment of tuberculosis. SQ109 acts by inhibiting MmpL3, a transporter of trehalose monomyclate, which is an important component of cellular wall. The drug was investigated as a monotherapy or in combination with rifampicin in phase II clinical trials in pulmonary tuberculosis patients. The clinical trials, however, did not demonstrate activity of SQ-109 alone or its ability to enhance the activity of rifampicin.
Status:
Investigational
Source:
NCT03678571: Not Applicable Interventional Completed Infertility
(2018)
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Latrunculin A is a naturally occurring toxin that can be purified from the red sea sponge Latrunculia magnifica. It disrupts actin polymerization and prevents mitotic spindle formation; therefore preventing proper cellular replication. It was discovered that latrunculin A has strong anticancer effects, and it was investigated as a treatment candidate for peritoneal dissemination of gastric cancer.
Status:
Investigational
Source:
NCT00935844: Phase 1 Interventional Completed Advanced Solid Tumors
(2009)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)



Millennium (a wholly-owned subsidiary of Takeda) was developing TAK- 901 for the treatment of cancer. TAK-901 is an inhibitor of Aurora A/B with IC50 of 21 nM/15 nM. It is not a potent inhibitor of cellular JAK2, c-Src or Abl. TAK-901 is in phase I clinical trials by Millennium Pharmaceuticals for the treatment of advanced hematological malignancies. TAK-901 had been in phase I clinical trials for solid tumors. However, this study was discontinued.
Status:
Investigational
Source:
NCT01371604: Phase 2 Interventional Completed Hepatitis C, Chronic
(2011)
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
NCT00233441: Phase 2/Phase 3 Interventional Completed Atrial Fibrillation
(2004)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Celivarone is a benzofuran derivative with a multifactorial mode of action including class IV Vaughan Williams’ electrophysiological as well as anti-adrenergic properties. It has no iodine and has a limited tissue accumulation compared with amiodarone. Celivarone exhibits effective anti-arrhythmic properties in several ventricular ischemia- or reperfusioninduced arrhythmia models as well as in in vitro and in vivo atrial fibrillation (AF) models. Its electrophysiological properties are similar to amiodarone (multifactorial mode of action) but with different relative effects on the ion channels. At the ventricular level, celivarone shows anti-arrhythmic activities by suppressing reperfusion-induced arrhythmias (i.v. and oral routes) and reducing the early mortality due to myocardial infarction (oral route) in rats models. At the atrial level, celivarone is effective in atrial fibrillation models with restoration of sinus rhythm or prevention of AF induction and AF recurrence.